Skip to main content
SpringerLink
Log in

Clinical and biochemical effects of citalopram, a selective 5-HT reuptake inhibitor — a dose-response study in depressed patients

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Citalopram is a bicyclic phtalane derivative. In animal experiments, citalopram has been demonstrated to possess a potent and highly selective inhibitory effect on serotonin reuptake. Several studies in man have indicated that citalopram given in daily doses of 40–60 mg has antidepressant properties and few side effects. The present double-blind study investigated the effects of three doses of citalopram (5 mg, 25 mg, and 50 mg) on depressive symptoms and various biochemical variables in 26 depressive patients. A significant reduction of the clinical ratings of depressive symptoms occurred at all dose levels. In endogenously depressed patients, a dose of 25 or 50 mg daily seemed to have the most pronounced antidepressive effect. The side effects were few and not related to dose level. A highly significant decrease in 5-HIAA in the CSF was found. MOPEG in the CSF was also significantly decreased, while HVA in the CSF was increased. In addition, a significant decrease in the plasma concentrations of valine, leucine, tyrosine, and histidine was found. None of the biochemical effects was dose-dependent. The complex pattern of biochemical effects indicate that the amelioration of depressive symptoms might be related to effects of citalopram on central monoaminergic mechanisms and peripheral amino acid concentrations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Åberg-Wistedt A, Alvariza M, Bertilsson L, Malmgren R, Wachtmeister H (1985) Alaproclate a novel antidepressant? A biochemical and clinical comparison with zimelidin. Acta Psychiatr Scand 71:256–268

    Google Scholar 

  • Åsberg M, Cronholm B, Sjöquist F, Tuck D (1970) Correlations of subjective side effects with plasma concentrations of nortriptyline. Br Med J 4:18–21

    Google Scholar 

  • Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1969) An inventory for measuring depression. Arch Gen Psychiatr 7:53–63

    Google Scholar 

  • Bech P (1984) Citalopram versus clomipramine: A controlled clinical study. Clin Neuropharmacol 7, suppl 1:876

    Google Scholar 

  • Bjerkenstedt L, Flyckt L, Fredricson-Overö K, Lindgjaerde O (1985) Relations between clinical effects, serum drug concentrations and serotonin uptake inhibition in depressed patients treated with citalopram: A double-blind comparison of three dose levels. Eur J Clin Pharmacol (in press)

  • Boeck V, Fredricson-Overö K, Svendsen O (1982) Studies on acute toxicity and drug levels of citalopram in the dog. Acta Pharmacol Toxicol 50:169–174

    Google Scholar 

  • Boeck V, Jörgensen A, Fredricson-Overö K (1984) Comparative animal studies on cardiovascular toxicity of tri- and tetracyclic antidepressants and citalopram; relation to drug plasma levels. Psychopharmacology 82:275–281

    Google Scholar 

  • Carlsson A (1965) Drugs which block the storage of 5-hydroxytryptamine and related amines. In: Erspamer V (ed) Handbuch der experimentellen Pharmakologic, 19. Springer, Berlin, pp 529–592

    Google Scholar 

  • Carroll BJ, Feinberg M, Greden JF, Tarika J, Albala AA, Haskett RF, James NM, Kronfol Z, Lohr N, Steiner M, de Vigne JP, Young E (1981) A specific laboratory test for the diagnosis of melancholia. Arch Gen Psychiatr 38:15–22

    Google Scholar 

  • Christensen AVB, Fjalland V, Pedersen P, Danneskiold-Samsöe P, Svendsen O (1977) Pharmacology of a new phthalane (Lu 10-171), with specific 5-HT uptake inhibiting properties. Eur J Pharmacol 41:153–162

    Google Scholar 

  • Curzon G (1972) Relationships between stress and brain 5-hydroxytryptamine and their possible significance in affective disorders. J Psychiatr Res 9:243–252

    Google Scholar 

  • de Wilde J, Mertens C, Fredricson-Overö K, Höpfner-Petersen HE (1985) Citalopram versus mianserin. A controlled double-blind trial in depressed patients. Acta Psychiatr Scand (in press)

  • Dray A, Gonye TJ, Oakley NR, Tanner T (1976) Evidence for the existence of raphe projection to the substantia nigra in rat. Brain Res 113:45–57

    Google Scholar 

  • Fernstrom JD, Faller DV (1978) Neutral amino acids in the brain: Changes in response to food ingestion. J Neurochem 30:1531–1538

    Google Scholar 

  • Fernstrom JD, Wurtman RJ (1972) Brain serotonin content: Physiological regulation by plasma neutral amino acids. Science 178:414–416

    Google Scholar 

  • Fuxe K (1965) Evidence for the existence of monoamine neurons in the central nervous system. Acta Physiol Scand 64, suppl 247:37–85

    Google Scholar 

  • Fuxe K, Ögren SO, Agnati R, Andersson R, Eneroth P (1982) On the mechanism of action of antidepressant drugs: Indications of reductions in 5-HT neurotransmission in some brain regions upon subchronic treatment. In: Langer SZ, Takahashi R, Segawa T, Briley M (eds) New vistas in depression. Pergamon Press, New York

    Google Scholar 

  • Gastpar M, Gastpar G (1982) Preliminary studies with Citalopram (Lu 10-171), as specific 5-HT reuptake inhibitor, as antidepressant. Prog Neuro-Psychopharmacol Biol Psychiatr 6:319–325

    Google Scholar 

  • Gottlieb P, Wandall T, Fredricson-Overö K (1980) Initial, clinical trial of a new specific 5-HT reuptake inhibitor, citalopram (Lu 10-171). Acta Psychiatr Scand 62:236–244

    Google Scholar 

  • Guldberg MC, Ashcroft GW, Crawford TBB (1966) Concentrations of 5-hydroxyindolyl acetic acid and homovanillic acid in the cerebrospinal fluid of the dog before and during treatment with probenecid. Life Sci 5:1571–1575

    Google Scholar 

  • Gurney C, Roth M, Garside RF, Kerr TA, Schapira K (1972) Studies in the classification of affective disorders. The relationship between state and depressive illnesses. Br J Psychiatr 121:162–166

    Google Scholar 

  • Hagenfeldt L, Bjekenstedt L, Edman G, Sedvall G, Wiesel FA (1984) Amino acids and monoamine metabolites in CSF-interrelationship in healthy subjects. J Neurochem 42:833–837

    Google Scholar 

  • Härnryd C, Bjerkenstedt L, Gullberg B, Oxenstierna G, Sedvall G, Wiesel FA (1984) Time course for effects of sulpiride and chlorpromazine on monamine metabolite and prolactin levels in cerbrospinal fluid from schizophrenic patients. Acta Psychiatr Scand 69:75–92

    Google Scholar 

  • Höpfner-Petersen HE, Fredricson-Overö K, Hyttel J (1978) Citalopram—en mulighed fur vudering af 5-HT teoriens anvendlighed ved depressionsbehandling. Nord Psykiat T 32:463–471

    Google Scholar 

  • Hyttel J (1977a) Neurochemical characterization of a new potent and selective serotonin uptake inhibitor: Lu 10-171. Psychopharmacology 51:225–233

    Google Scholar 

  • Hyttel J (1977b) Effect of a selective 5-HT uptake inhibitor — Lu 10-171 — on rat brain 5-HT turnover. Acta Pharmacol Toxicol 40:439–446

    Google Scholar 

  • Hyttel J (1978) Effect of a specific 5-HT uptake inhibitor, citalopram (Lu 10-171), on 3H-5-HT uptake in rat brain synaptosomes in vitro. Psychopharmacology 60:13–18

    Google Scholar 

  • Hyttel J (1981) Similarities between the binding of 3H-pifluxitol and 3H-flupentixol to rat striatal dopamine receptors in vitro. Life Sci 28:563–569

    Google Scholar 

  • Hyttel J (1982) Citalopram, pharmacological profile of specific serotonin uptake inhibitor with antidepressant activity. Prog Neuropsychopharmacol Biol Psychiatr 6:275–336

    Google Scholar 

  • Langer SZ, Moret C, Raisman R, Dubocovik ML, Burley M (1980) High affinity (3H)-imipramine binding in rat hypothalamus: Association with uptake of serotonin but not of norepinephrine. Science 210:1133–1135

    Google Scholar 

  • Lapin IP, Oxenkrug GF (1969) Intensification of the central serotoninergic processes as possible determinant of the thymoleptic effect. Lancet i:132–136

    Google Scholar 

  • Leighton WP, Rosenblatt S, Chanley JD (1983) Lithium-induced changes in plasma amino acid levels during treatment of affective disorders. Psychiatr Res 8:33–40

    Google Scholar 

  • Lindegaard-Pedersen O, Kragh-Sörensen P, Bjerre M, Fredricson-Overö K, Gram LF (1982) Citalopram, a selective serotonin reuptake inhibitor; clinical antidepressive and long-term effect — a phase II study. Psychopharmacology 77:199–204

    Google Scholar 

  • Maitre L, Moser P, Baumann PA, Waldmeier PC (1980) Amine uptake inhibitors: Criteria of selectivity. Acta Psychiatr Scand 61, suppl 280:97–110

    Google Scholar 

  • Möller SE, Kirk L, Honore P (1980) Relationship between plasma ratio of tryptophan to competing amino acids and the response to l-trypophan treatment in endogenously depressed patients. J Affect Dis 2:47–59

    Google Scholar 

  • Möller SR, Honore P, Larsen OB (1983) Tryptophan and tyrosine ratios to neutral amino acids in endogenously depression. J Affect Dis 5:67–79

    Google Scholar 

  • Möller SE, Reisby N, Ortmann J, Elley J, Krautwald O (1981) Relevance of tryptophan and tyrosine availability in endogenous and “nonendogenous” depressive treated with imipramine and clomipramine. J Affect Dis 3:231–243

    Google Scholar 

  • Montgomery SA, Åsberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatr 134:382–389

    Google Scholar 

  • Öfsti E (1982) Citalopram — a specific 5-HT reuptake inhibitor — as an antidepressant drug: A phase II multicentre trial. Prog Neuro-Psychopharmacol Biol Psychiatr 6:327–335

    Google Scholar 

  • Pardridge WM, Oldendorf WH (1977) Transport of metabolic substrates through the blood brain barrier. J Neurochem 28:5–12

    Google Scholar 

  • Rastogi RB, Singhal RL, Lapierre YD (1981) Effects of short- and long-term neuroleptic treatment on brain serotonin synthesis and turnover: Focus on the serotonin hypothesis of schizophrenia. Life Sci 39:753–741

    Google Scholar 

  • Schubert J (1973) Effect of chronic lithium treatment on monoamine metabolism in rat brain. Psychopharmacology 32:301–311

    Google Scholar 

  • Schubert J, Nybäck H, Sedvall G (1970) Effect of antidepressant drugs on accumulation and disappearance of monoamines formed in vivo from labelled precursors in mouse brain. J Pharm Pharmacol 22:136–139

    Google Scholar 

  • Shapiro SS, Wilk MB (1965) An analysis of variance test for normality (complete samples). Biometrika 52:591–611

    Google Scholar 

  • Sjöqvist F (1971) A pharmacokinetic approach to the treatment of depression. Int Pharmacopsychiatr 6:147–169

    Google Scholar 

  • Spitzer RL, Endicott J, Robins E (1978) Research Diagnostic Criteria (RDC) for a selected group of functional disorders, 3rd edition. New York State Psychiatric Institute

  • Swahn CG, Sandgärde B, Wiesel FA, Sedvall G (1976) Simultaneous determination of three major monoamine metabolites in brain tissue and body fluids by mass fragmentographic methods. Psychopharmacology 48:157–162

    Google Scholar 

  • Waldmeier PC (1980) Serotonergic modulation of mesolimbic and frontal cortical dopamine neurons. Experentia 36:1092–1094

    Google Scholar 

  • Winer BJ (1971) Statistical principles in experimental design, 2nd edition. New York, McGraw Hill

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry and Psychology, Karolinska Institute, S-18288, Stockholm, Sweden

    L. Bjerkenstedt, G. Edman, L. Flyckt, G. Sedvall & F. A. Wiesel

  2. Department of Clinical Chemistry, Karolinska Institute, S-18288, Stockholm, Sweden

    L. Hagenfeldt

Authors
  1. L. Bjerkenstedt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Edman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L. Flyckt
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. L. Hagenfeldt
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. G. Sedvall
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. F. A. Wiesel
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bjerkenstedt, L., Edman, G., Flyckt, L. et al. Clinical and biochemical effects of citalopram, a selective 5-HT reuptake inhibitor — a dose-response study in depressed patients. Psychopharmacology 87, 253–259 (1985). https://doi.org/10.1007/BF00432703

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00432703

Key words

Search

Navigation